A federally compliant cannabinoid drug developer says the DEA excluded it from the one hearing where its evidence mattered most, then watched the agency's own scientist testify to the very gap it
A federally compliant cannabinoid drug developer says the DEA excluded it from the one hearing where its evidence mattered most, then watched the agency's own scientist testify to the very gap it